Clinical Trials Directory

Trials / Completed

CompletedNCT01699542

WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture

A Multi-Center, Prospective, Randomized (RCT) Study Comparing WallFlex® Esophageal Fully Covered (FC) Metal Stent to Bougie Dilation for the Treatment of Refractory Anastomotic Esophageal Strictures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this of this study is to compare the safety and effectiveness of temporary indwell of the WallFlex Esophageal FC Metal Stent to Bougie Dilation for the treatment of refractory anastomotic esophageal strictures

Conditions

Interventions

TypeNameDescription
DEVICEWallFlex Esophageal RX Fully Covered StentTemporary placement of the WallFlex Esophageal RX Fully Covered Stent for treatment of refractory anastomotic esophageal strictures. The stent will be removed after 8 weeks (plus or minus 7 days) indwell
DEVICEEsophageal Bougie Dilator Per Investigator preferenceCommercially available Esophageal Bougie Dilator Per Investigator preference

Timeline

Start date
2013-12-23
Primary completion
2016-09-25
Completion
2016-09-25
First posted
2012-10-03
Last updated
2021-06-28
Results posted
2021-06-28

Locations

4 sites across 3 countries: Brazil, Netherlands, Sweden

Source: ClinicalTrials.gov record NCT01699542. Inclusion in this directory is not an endorsement.